|
Category: antimicrobial preservatives
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Appearance: | white crystalline powder (est) |
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Boiling Point: | 447.00 to 448.00 °C. @ 760.00 mm Hg (est)
|
| Flash Point: | 436.00 °F. TCC ( 224.40 °C. ) (est)
|
| logP (o/w): | 3.486 (est) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| European information : |
| Most important hazard(s): | | Xn N - Harmful, Dangerous for the environment. |
R 52/53 - Harmful to qauatic organisms, may cause long-term adverse effects in the aquatic environment. S 22 - Do not breath dust.
|
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
oral-rat LD50 400 mg/kg "Prehled Prumyslove Toxikologie; Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986Vol. -, Pg. 832, 1986.
|
| Dermal Toxicity: |
skin-rat LD50 > 5000 mg/kg Farmaco. Vol. 53, Pg. 405, 1998.
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | antimicrobial preservatives |
| Recommendation for climbazole usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for climbazole flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
| | 1-(4-chlorophenoxy)-1-imidazol-1-yl-3,3-dimethylbutan-2-one |
| NIST Chemistry WebBook: | Search Inchi |
| Pubchem (cid): | 37907 |
| Pubchem (sid): | 135001046 |
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | baypival | | | baysan | | 2- | butanone, 1-(4-chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethyl- | | 2- | butanone, 1-(p-chlorophenoxy)-3,3-dimethyl-1-(1-imidazolyl)- | | 1-(4- | chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethyl-2-butanone | | 1-(4- | chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethylbutan-2-one | | 1-(4- | chlorophenoxy)-1-(1H-imidazolyl)-3,3-dimethyl-2-butanone | | 1-(4- | chlorophenoxy)-1-(imidazol-1-yl)-3,3-dimethyl butanone | | 1-(4- | chlorophenoxy)-1-(imidazol-1-yl)-3,3-dimethylbutanone | | 1-(p- | chlorophenoxy)-1-imidazol-1-yl-3,3-dimethyl-2-butanone | | 1-(4- | chlorophenoxy)-1-imidazolyl-3,3-dimethylbutan-2-one | | 1-(p- | chlorophenoxy)-3,3-dimethyl-1-(1-imidazolyl)-2-butanone | | 1-(4- | clorophenoxy)-3,3-dimethyl-1-(imidazole-1-yl)-2-butanone | | | crinipan AD (Symrise) |
Articles:
|